The funding for the Celestin Angel Wheel has been secured.

Collaboration in Treg research was initiated with Professor Yisong Wan from the University of North Carolina in the United States.

Signed a development agreement with a well-known CDMO in the domestic market, initiating systematic CMC development.

Complete the construction of the GMP workshop to meet the requirements of IIT and Phase I of clinical trials.

The preliminary research report on animal pharmacology has been completed.

Commence formal pre-clinical research: initiate efficacy studies, finalize pharmacokinetic and toxicity protocols.

Launch China IIT research